Home > Healthcare > Drug Device Combination > Therapeutic Systems > Plantar Fasciitis Treatment Market

Plantar Fasciitis Treatment Market Trends

  • Report ID: GMI8660
  • Published Date: Mar 2024
  • Report Format: PDF

Plantar Fasciitis Treatment Market Trends

The market is witnessing several notable trends that are shaping its growth and development. Factors such as ongoing technological innovations in medical technology, increasing need for integrated wearable devices and digital health solutions, rising emphasis on personalized medicine, and a surging demand for telemedicine and remote monitoring, among other factors are propelling the industry growth.

  • Further, there is a growing demand for minimally invasive procedures in the treatment of plantar fasciitis. Minimally invasive techniques such as percutaneous fasciotomy, endoscopic plantar fasciotomy, and ultrasound-guided injections offer less traumatic alternatives to traditional open surgery, resulting in shorter recovery times, reduced postoperative pain, and improved patient satisfaction. As patients and healthcare providers increasingly prioritize minimally invasive approaches, the demand for these procedures is expected to rise, influencing the market landscape.
  • Moreover, wearable devices such as foot orthotics, plantar pressure sensors, and activity trackers are being integrated into plantar fasciitis treatment regimens to monitor foot biomechanics, track activity levels, and optimize treatment outcomes. Digital health solutions, including mobile applications and web-based platforms, offer resources for self-monitoring, exercise guidance, and communication with healthcare providers, enhancing patient engagement and compliance.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Plantar fasciitis treatment industry size was USD 1.2 billion in 2023 and is set to expand at 9.3% CAGR from 2024-2032 driven by the ongoing advancements in technology, an increase in the prevalence of plantar fasciitis, and the rising demand for minimally invasive procedures

Plantar fasciitis treatment market from the orthotic devices segment generated USD 229.9 million in revenue in 2023 and is projected to witness high demand through 2032 as these devices are designed to provide support, alignment, and cushioning to the foot.

North America plantar fasciitis treatment industry size was USD 498.4 million in 2023 and is set to exhibit robust growth through 2032 owing to the surging need for effective treatment options, including conservative therapies, advanced interventions, and surgical procedures in the region.

Some of the top plantar fasciitis treatment companies are 3M, A. Algeo Ltd., Bauerfeind USA Inc., Hanger, Inc., OrthoBethesda, OrthoMed, Inc., Ottobock, Pfizer, Inc., Revance, Therapeutics, Inc., Sanofi, and Shapecrunch.

Plantar Fasciitis Treatment Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 441
  • Countries covered: 22
  • Pages: 230
 Download Free Sample